Key result
CMR guides SCD risk stratification and facilitates successful VT ablation in structural heart disease.
CMR is a useful non-invasive tool for sudden cardiac death risk stratification and facilitating successful radiofrequency ablation of VT in patients with structural heart disease.
May support CMR for SCD risk stratification and VT ablation guidance in structural heart disease; hypothesis-generating, requires prospective validation.
Treatment for ventricular tachycardia (VT) generally includes 1 or more of the following options: antiarrhythmic therapy, an implantable cardioverter-defibrillator and/or catheter ablation. Catheter ablation is performed with an electroanatomic mapping system to define the heart's 3D anatomy, as well as regions of scar. Radiofrequency energy is then applied to areas of abnormal substrate within which are located channels critical to the VT circuit. Cardiac magnetic resonance (CMR) imaging is a non-invasive modality that provides high-resolution images of cardiac structure and function. CMR has become a very useful tool for sudden cardiac death risk stratification and to facilitate successful radiofrequency ablation of VT in patients with abnormal cardiac substrate. The role of CMR in the management and treatment of VT in patients with structural heart disease is reviewed.
No takes yet. Share an insight, caveat, or question.
Mehrotra et al. (2015) conducted a review in Ventricular Tachycardia in Patients With Structural Heart Disease. Cardiac Magnetic Resonance (CMR) imaging was evaluated. Cardiac magnetic resonance imaging is a useful tool for sudden cardiac death risk stratification and facilitates successful radiofrequency ablation of ventricular tachycardia in structural heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: